![Page 1: Syllabus M Pharm - Welcome to BIT Mesra · Syllabus_M_Pharm.pdf Author: VJ Created Date: 8/20/2018 10:10:50 AM](https://reader034.vdocuments.us/reader034/viewer/2022042214/5eb8fdcd0312356a3c3a9a12/html5/thumbnails/1.jpg)
![Page 2: Syllabus M Pharm - Welcome to BIT Mesra · Syllabus_M_Pharm.pdf Author: VJ Created Date: 8/20/2018 10:10:50 AM](https://reader034.vdocuments.us/reader034/viewer/2022042214/5eb8fdcd0312356a3c3a9a12/html5/thumbnails/2.jpg)
CHAPTER –I:REGULATIONS1. Short Title and Commencement
2. Minimum qualification for admission
3. Duration of the program
4. Medium of instruction and examinations
5. Working days in each semester
![Page 3: Syllabus M Pharm - Welcome to BIT Mesra · Syllabus_M_Pharm.pdf Author: VJ Created Date: 8/20/2018 10:10:50 AM](https://reader034.vdocuments.us/reader034/viewer/2022042214/5eb8fdcd0312356a3c3a9a12/html5/thumbnails/3.jpg)
6. Attendance and progress
7. Program/Course credit structure
7.1. Credit assignment7.1.1. Theory and Laboratory courses
7.2. Minimum credit requirements
![Page 4: Syllabus M Pharm - Welcome to BIT Mesra · Syllabus_M_Pharm.pdf Author: VJ Created Date: 8/20/2018 10:10:50 AM](https://reader034.vdocuments.us/reader034/viewer/2022042214/5eb8fdcd0312356a3c3a9a12/html5/thumbnails/4.jpg)
8. Academic work
9. Course of study
Table – 1: List of M.Pharm. Specializations and their CodeS. No. Specialization Code
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
![Page 5: Syllabus M Pharm - Welcome to BIT Mesra · Syllabus_M_Pharm.pdf Author: VJ Created Date: 8/20/2018 10:10:50 AM](https://reader034.vdocuments.us/reader034/viewer/2022042214/5eb8fdcd0312356a3c3a9a12/html5/thumbnails/5.jpg)
CourseCode
CourseCreditHours
CreditPoints
Hrs./wk
Marks
Semester I
MPH101T
MPH102T
MPH103T
MPH104T
MPH105P
-
Total 35 26 35 650
Semester II
MPH201T
MPH202T
MPH203T
MPH204T
MPH205P
-
Total 35 26 35 650
![Page 6: Syllabus M Pharm - Welcome to BIT Mesra · Syllabus_M_Pharm.pdf Author: VJ Created Date: 8/20/2018 10:10:50 AM](https://reader034.vdocuments.us/reader034/viewer/2022042214/5eb8fdcd0312356a3c3a9a12/html5/thumbnails/6.jpg)
(Common for All Specializations)CourseCode
CourseCreditHours
CreditPoints
MRM 301T
-
-
-
Total 35 21
*
(Common for All Specializations)CourseCode
CourseCreditHours
CreditPoints
-
-
-
Total 35 20
Semester Credit Points
I
II
III
IV
Co-curricular Activities(Attending Conference, Scientific Presentations andOther Scholarly Activities)
Total Credit Points
![Page 7: Syllabus M Pharm - Welcome to BIT Mesra · Syllabus_M_Pharm.pdf Author: VJ Created Date: 8/20/2018 10:10:50 AM](https://reader034.vdocuments.us/reader034/viewer/2022042214/5eb8fdcd0312356a3c3a9a12/html5/thumbnails/7.jpg)
Name of the ActivityMaximum Credit Points
Eligible / Activity
Participation in National LevelSeminar/Conference/Workshop/Symposium/ TrainingPrograms (related to the specialization of the student)
Participation in international LevelSeminar/Conference/Workshop/Symposium/ TrainingPrograms (related to the specialization of the student)
Academic Award/Research Award from StateLevel/National Agencies
Academic Award/Research Award from InternationalAgencies
Research / Review Publication in National Journals(Indexed in Scopus / Web of Science)
Research / Review Publication in International Journals(Indexed in Scopus / Web of Science)
10. Program Committee
![Page 8: Syllabus M Pharm - Welcome to BIT Mesra · Syllabus_M_Pharm.pdf Author: VJ Created Date: 8/20/2018 10:10:50 AM](https://reader034.vdocuments.us/reader034/viewer/2022042214/5eb8fdcd0312356a3c3a9a12/html5/thumbnails/8.jpg)
11. Examinations/Assessments
11.1. End semester examinations
![Page 9: Syllabus M Pharm - Welcome to BIT Mesra · Syllabus_M_Pharm.pdf Author: VJ Created Date: 8/20/2018 10:10:50 AM](https://reader034.vdocuments.us/reader034/viewer/2022042214/5eb8fdcd0312356a3c3a9a12/html5/thumbnails/9.jpg)
Internal AssessmentEnd
SemesterExams
SessionalExams
CourseCode
CourseContinu
ousMode
Marks
Duration
Total
Marks
Duration
Total
Marks
SEMESTER I
MPH101T
MPH102T
MPH103T
MPH104T
MPH105P
-
Total 650
SEMESTER II
MPH201T
MPH202T
MPH203T
MPH
![Page 10: Syllabus M Pharm - Welcome to BIT Mesra · Syllabus_M_Pharm.pdf Author: VJ Created Date: 8/20/2018 10:10:50 AM](https://reader034.vdocuments.us/reader034/viewer/2022042214/5eb8fdcd0312356a3c3a9a12/html5/thumbnails/10.jpg)
204T
MPH205P
-
Total 650
![Page 11: Syllabus M Pharm - Welcome to BIT Mesra · Syllabus_M_Pharm.pdf Author: VJ Created Date: 8/20/2018 10:10:50 AM](https://reader034.vdocuments.us/reader034/viewer/2022042214/5eb8fdcd0312356a3c3a9a12/html5/thumbnails/11.jpg)
Internal AssessmentEnd Semester
Exams
SessionalExams
CourseCode
Course Continuou
sMode
Marks
Duration
Total
Marks
Duration
Total
Marks
SEMESTER III
MRM301T
-
-
-
Total 525
SEMESTER IV
-
-
-
Total 500
*Non University Examination
![Page 12: Syllabus M Pharm - Welcome to BIT Mesra · Syllabus_M_Pharm.pdf Author: VJ Created Date: 8/20/2018 10:10:50 AM](https://reader034.vdocuments.us/reader034/viewer/2022042214/5eb8fdcd0312356a3c3a9a12/html5/thumbnails/12.jpg)
11.2. Internal assessment: Continuous mode
Theory
Criteria Maximum Marks
Attendance (Refer Table – 28)
Student – Teacher interaction
Total 10
Practical
Attendance (Refer Table – 28
Based on Practical Records, Regular viva voce, etc.
Total 20
Percentage of Attendance Theory Practical
95 – 100
90 – 94
85 – 89
80 – 84
Less than 80
11.2.1. Sessional Exams
12. Promotion and award of grades
13. Carry forward of marks
![Page 13: Syllabus M Pharm - Welcome to BIT Mesra · Syllabus_M_Pharm.pdf Author: VJ Created Date: 8/20/2018 10:10:50 AM](https://reader034.vdocuments.us/reader034/viewer/2022042214/5eb8fdcd0312356a3c3a9a12/html5/thumbnails/13.jpg)
14. Improvement of internal assessment
15. Reexamination of end semester examinations
Semester For Regular Candidates For Failed Candidates
I and III
II and IV
16. Allowed to keep terms (ATKT):
17. Grading of performances17.1. Letter grades and grade points allocations:
![Page 14: Syllabus M Pharm - Welcome to BIT Mesra · Syllabus_M_Pharm.pdf Author: VJ Created Date: 8/20/2018 10:10:50 AM](https://reader034.vdocuments.us/reader034/viewer/2022042214/5eb8fdcd0312356a3c3a9a12/html5/thumbnails/14.jpg)
PHARMACEUTICS(MPH)
MODERN PHARMACEUTICAL ANALYTICAL TECHNIQUES(MPH 101T)
Scope
Objectives
•
•
•
THEORY 60 HOURSUV-Visible spectroscopy
IR spectroscopy
Spectroflourimetry:
Flame emission spectroscopy and Atomic absorptionspectroscopy
NMR spectroscopy
![Page 15: Syllabus M Pharm - Welcome to BIT Mesra · Syllabus_M_Pharm.pdf Author: VJ Created Date: 8/20/2018 10:10:50 AM](https://reader034.vdocuments.us/reader034/viewer/2022042214/5eb8fdcd0312356a3c3a9a12/html5/thumbnails/15.jpg)
Mass Spectroscopy
Chromatography
Electrophoresis
b. X ray Crystallography
Immunological assays :
REFERENCES
![Page 16: Syllabus M Pharm - Welcome to BIT Mesra · Syllabus_M_Pharm.pdf Author: VJ Created Date: 8/20/2018 10:10:50 AM](https://reader034.vdocuments.us/reader034/viewer/2022042214/5eb8fdcd0312356a3c3a9a12/html5/thumbnails/16.jpg)
SCOPE
DRUG DELIVERY SYSTEMS(MPH 102T)
OBJECTIVES
THEORY 60 Hrs
Sustained Release(SR) and Controlled Release (CR)formulations:
Rate Controlled Drug Delivery Systems:
Gastro-Retentive Drug Delivery Systems
Occular Drug Delivery Systems
![Page 17: Syllabus M Pharm - Welcome to BIT Mesra · Syllabus_M_Pharm.pdf Author: VJ Created Date: 8/20/2018 10:10:50 AM](https://reader034.vdocuments.us/reader034/viewer/2022042214/5eb8fdcd0312356a3c3a9a12/html5/thumbnails/17.jpg)
Transdermal Drug Delivery Systems:
Protein and Peptide Delivery:
Vaccine delivery systems:
REFERENCES
JOURNALS
![Page 18: Syllabus M Pharm - Welcome to BIT Mesra · Syllabus_M_Pharm.pdf Author: VJ Created Date: 8/20/2018 10:10:50 AM](https://reader034.vdocuments.us/reader034/viewer/2022042214/5eb8fdcd0312356a3c3a9a12/html5/thumbnails/18.jpg)
Scope
MODERN PHARMACEUTICS(MPH 103T)
Objectives
•
•
•
•
•THEORY 60 HRS
Preformation Concepts –
Optimization techniques in Pharmaceutical Formulation
Validation :
cGMP & Industrial Management
![Page 19: Syllabus M Pharm - Welcome to BIT Mesra · Syllabus_M_Pharm.pdf Author: VJ Created Date: 8/20/2018 10:10:50 AM](https://reader034.vdocuments.us/reader034/viewer/2022042214/5eb8fdcd0312356a3c3a9a12/html5/thumbnails/19.jpg)
Compression and compaction
Study of consolidation parameters
REFERENCES
![Page 20: Syllabus M Pharm - Welcome to BIT Mesra · Syllabus_M_Pharm.pdf Author: VJ Created Date: 8/20/2018 10:10:50 AM](https://reader034.vdocuments.us/reader034/viewer/2022042214/5eb8fdcd0312356a3c3a9a12/html5/thumbnails/20.jpg)
Scope
REGULATORY AFFAIRS(MPH 104T)
•
•
•
•Objectives:
•
•
•
••
•
•
THEORY 60 Hrs
Documentation in Pharmaceutical industry
Regulatory requirement for product approval
![Page 21: Syllabus M Pharm - Welcome to BIT Mesra · Syllabus_M_Pharm.pdf Author: VJ Created Date: 8/20/2018 10:10:50 AM](https://reader034.vdocuments.us/reader034/viewer/2022042214/5eb8fdcd0312356a3c3a9a12/html5/thumbnails/21.jpg)
Non clinical drug development:
Clinical trials:
REFERENCES
![Page 22: Syllabus M Pharm - Welcome to BIT Mesra · Syllabus_M_Pharm.pdf Author: VJ Created Date: 8/20/2018 10:10:50 AM](https://reader034.vdocuments.us/reader034/viewer/2022042214/5eb8fdcd0312356a3c3a9a12/html5/thumbnails/22.jpg)
PHARMACEUTICS PRACTICALS - I(MPH 105P)
In-vitro
![Page 23: Syllabus M Pharm - Welcome to BIT Mesra · Syllabus_M_Pharm.pdf Author: VJ Created Date: 8/20/2018 10:10:50 AM](https://reader034.vdocuments.us/reader034/viewer/2022042214/5eb8fdcd0312356a3c3a9a12/html5/thumbnails/23.jpg)
MOLECULAR PHARMACEUTICS (NANO TECHNOLOGY &TARGETED DDS) (NTDS)
(MPH 201T)Scope
Objectives
•
•
•
THEORY 60 Hrs
Targeted Drug Delivery Systems: C
Targeting Methods
Micro Capsules / Micro Spheres:
Pulmonary Drug Delivery Systems
REFERENCES
![Page 24: Syllabus M Pharm - Welcome to BIT Mesra · Syllabus_M_Pharm.pdf Author: VJ Created Date: 8/20/2018 10:10:50 AM](https://reader034.vdocuments.us/reader034/viewer/2022042214/5eb8fdcd0312356a3c3a9a12/html5/thumbnails/24.jpg)
ADVANCED BIOPHARMACEUTICS & PHARMACOKINETICS(MPH 202T)
Scope
Objectives
••
•
•
•
THEORY 60 Hrs
Drug Absorption from the Gastrointestinal Tract
![Page 25: Syllabus M Pharm - Welcome to BIT Mesra · Syllabus_M_Pharm.pdf Author: VJ Created Date: 8/20/2018 10:10:50 AM](https://reader034.vdocuments.us/reader034/viewer/2022042214/5eb8fdcd0312356a3c3a9a12/html5/thumbnails/25.jpg)
Biopharmaceutic considerations in drug product designand In Vitro Drug Product Performance:
in vitro
In vitro in vivo
Pharmacokinetics:
Drug Product Performance, In Vivo: Bioavailability andBioequivalence
Application of Pharmacokinetics:
![Page 26: Syllabus M Pharm - Welcome to BIT Mesra · Syllabus_M_Pharm.pdf Author: VJ Created Date: 8/20/2018 10:10:50 AM](https://reader034.vdocuments.us/reader034/viewer/2022042214/5eb8fdcd0312356a3c3a9a12/html5/thumbnails/26.jpg)
REFERENCES
![Page 27: Syllabus M Pharm - Welcome to BIT Mesra · Syllabus_M_Pharm.pdf Author: VJ Created Date: 8/20/2018 10:10:50 AM](https://reader034.vdocuments.us/reader034/viewer/2022042214/5eb8fdcd0312356a3c3a9a12/html5/thumbnails/27.jpg)
Scope
COMPUTER AIDED DRUG DEVELOPMENT(MPH 203T)
Objectives
••
•
•
•
•
•
•
THEORY 60 Hrs
Computers in Pharmaceutical Research andDevelopment
Quality-by-Design In Pharmaceutical Development:
![Page 28: Syllabus M Pharm - Welcome to BIT Mesra · Syllabus_M_Pharm.pdf Author: VJ Created Date: 8/20/2018 10:10:50 AM](https://reader034.vdocuments.us/reader034/viewer/2022042214/5eb8fdcd0312356a3c3a9a12/html5/thumbnails/28.jpg)
Computer-aided formulation development :
Computer-aided biopharmaceutical characterization
in vitro-in vivo
Computer Simulations in Pharmacokinetics andPharmacodynamics:
Computers in Clinical Development
Artificial Intelligence (AI), Robotics and Computational fluiddynamics:
REFERENCES
![Page 29: Syllabus M Pharm - Welcome to BIT Mesra · Syllabus_M_Pharm.pdf Author: VJ Created Date: 8/20/2018 10:10:50 AM](https://reader034.vdocuments.us/reader034/viewer/2022042214/5eb8fdcd0312356a3c3a9a12/html5/thumbnails/29.jpg)
Scope
COSMETICS AND COSMECEUTICALS(MPH 204T)
Objectives
•
•
•
•
•
THEORY 60 Hrs
Cosmetics – Regulatory :
Cosmetics - Biological aspects :
Formulation Building blocks:
Perfumes
![Page 30: Syllabus M Pharm - Welcome to BIT Mesra · Syllabus_M_Pharm.pdf Author: VJ Created Date: 8/20/2018 10:10:50 AM](https://reader034.vdocuments.us/reader034/viewer/2022042214/5eb8fdcd0312356a3c3a9a12/html5/thumbnails/30.jpg)
Controversial ingredients:
Design of cosmeceutical products:
Herbal Cosmetics :
REFERENCES
![Page 31: Syllabus M Pharm - Welcome to BIT Mesra · Syllabus_M_Pharm.pdf Author: VJ Created Date: 8/20/2018 10:10:50 AM](https://reader034.vdocuments.us/reader034/viewer/2022042214/5eb8fdcd0312356a3c3a9a12/html5/thumbnails/31.jpg)
PHARMACEUTICS PRACTICALS - II(MPH 205P)
In vitro
![Page 32: Syllabus M Pharm - Welcome to BIT Mesra · Syllabus_M_Pharm.pdf Author: VJ Created Date: 8/20/2018 10:10:50 AM](https://reader034.vdocuments.us/reader034/viewer/2022042214/5eb8fdcd0312356a3c3a9a12/html5/thumbnails/32.jpg)
Semester IIIMRM 301T - Research Methodology & Biostatistics
UNIT – I
General Research Methodology:
UNIT – II
Biostatistics:
UNIT – III
Medical Research:
UNIT – IV
CPCSEA guidelines for laboratory animal facility:
UNIT – V
Declaration of Helsinki:
![Page 33: Syllabus M Pharm - Welcome to BIT Mesra · Syllabus_M_Pharm.pdf Author: VJ Created Date: 8/20/2018 10:10:50 AM](https://reader034.vdocuments.us/reader034/viewer/2022042214/5eb8fdcd0312356a3c3a9a12/html5/thumbnails/33.jpg)